185 related articles for article (PubMed ID: 9927512)
1. Growth inhibition and apoptosis due to restoration of E2A activity in T cell acute lymphoblastic leukemia cells.
Park ST; Nolan GP; Sun XH
J Exp Med; 1999 Feb; 189(3):501-8. PubMed ID: 9927512
[TBL] [Abstract][Full Text] [Related]
2. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells.
Hsu HL; Wadman I; Baer R
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3181-5. PubMed ID: 8159721
[TBL] [Abstract][Full Text] [Related]
3. Coordinate expression and developmental role of Id2 protein and TAL1/E2A heterodimer in erythroid progenitor differentiation.
Condorelli G; Vitelli L; Valtieri M; Marta I; Montesoro E; Lulli V; Baer R; Peschle C
Blood; 1995 Jul; 86(1):164-75. PubMed ID: 7540882
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.
Palomero T; Odom DT; O'Neil J; Ferrando AA; Margolin A; Neuberg DS; Winter SS; Larson RS; Li W; Liu XS; Young RA; Look AT
Blood; 2006 Aug; 108(3):986-92. PubMed ID: 16621969
[TBL] [Abstract][Full Text] [Related]
5. The DNA binding activity of TAL-1 is not required to induce leukemia/lymphoma in mice.
O'Neil J; Billa M; Oikemus S; Kelliher M
Oncogene; 2001 Jun; 20(29):3897-905. PubMed ID: 11439353
[TBL] [Abstract][Full Text] [Related]
6. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation.
Voronova AF; Lee F
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5952-6. PubMed ID: 8016095
[TBL] [Abstract][Full Text] [Related]
7. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins.
Hsu HL; Huang L; Tsan JT; Funk W; Wright WE; Hu JS; Kingston RE; Baer R
Mol Cell Biol; 1994 Feb; 14(2):1256-65. PubMed ID: 8289805
[TBL] [Abstract][Full Text] [Related]
8. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL.
Ono Y; Fukuhara N; Yoshie O
J Biol Chem; 1997 Feb; 272(7):4576-81. PubMed ID: 9020185
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin stimulates transcription of the TAL1/SCL gene and phosphorylation of its protein products.
Prasad KS; Jordan JE; Koury MJ; Bondurant MC; Brandt SJ
J Biol Chem; 1995 May; 270(19):11603-11. PubMed ID: 7744799
[TBL] [Abstract][Full Text] [Related]
11. E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Sykes DB; Kamps MP
Mol Cell Biol; 2004 Feb; 24(3):1256-69. PubMed ID: 14729970
[TBL] [Abstract][Full Text] [Related]
12. The Tal1 oncoprotein inhibits E47-mediated transcription. Mechanism of inhibition.
Park ST; Sun XH
J Biol Chem; 1998 Mar; 273(12):7030-7. PubMed ID: 9507011
[TBL] [Abstract][Full Text] [Related]
13. Sequence determinants of DNA binding by the hematopoietic helix-loop-helix transcription factor TAL1: importance of sequences flanking the E-box core.
Gould KA; Bresnick EH
Gene Expr; 1998; 7(2):87-101. PubMed ID: 9699481
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein.
Hsu HL; Wadman I; Tsan JT; Baer R
Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5947-51. PubMed ID: 8016094
[TBL] [Abstract][Full Text] [Related]
15. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
16. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
17. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB.
O'Neil J; Shank J; Cusson N; Murre C; Kelliher M
Cancer Cell; 2004 Jun; 5(6):587-96. PubMed ID: 15193261
[TBL] [Abstract][Full Text] [Related]
18. Cross talk between expression of the human T-cell leukemia virus type 1 Tax transactivator and the oncogenic bHLH transcription factor TAL1.
Terme JM; Wencker M; Favre-Bonvin A; Bex F; Gazzolo L; Duc Dodon M; Jalinot P
J Virol; 2008 Aug; 82(16):7913-22. PubMed ID: 18495761
[TBL] [Abstract][Full Text] [Related]
19. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia.
Sanda T; Lawton LN; Barrasa MI; Fan ZP; Kohlhammer H; Gutierrez A; Ma W; Tatarek J; Ahn Y; Kelliher MA; Jamieson CH; Staudt LM; Young RA; Look AT
Cancer Cell; 2012 Aug; 22(2):209-21. PubMed ID: 22897851
[TBL] [Abstract][Full Text] [Related]
20. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
